
    
      The primary aim of this study is to assess the value of antioxidant intake on the pregnancy
      rate in IVF/ICSI (invitro-fertilization/intracytoplasmic sperm injection) cycles in poor
      responders. when the participants fulfill the eligibility criteria, informed consent will be
      taken. Block randomization will be done and the patients are allocated to one of two groups.
      The first group will take the antioxidant tablet daily orally for one month before the
      IVF/ICSI cycle. the other group will take placebo following the same regimen as the study
      group. Antagonist protocol will be done for all participants. Ovum pick up will be done under
      general anesthesia when one or more oocytes reaches 17 mm. The researchers will do embryo
      transfer on day 2 or 3 after ovum pickup. pregnancy test will be in blood after 2 weeks of
      embryo transfer.
    
  